tirzepatide sleep apnea fda approval GLP-1 medication is known to improve apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor of medicine at Brigham and Breakthrough Treatment for Obstructive Sleep

The effect of GLP-1 RA exposure compared with those not exposed indicated around 30% lower ferritin levels (95% CI 10% to 40%) (figure 2A, green line)

However, most have risks when combined with alcohol

Specific situations warrant urgent professional dietary consultation: Unintentional excessive weight loss losing more than 1 kg weekly consistently, or experiencing rapid weight loss that feels uncontrolled Inability to meet minimum calorie requirements due to severe appetite suppression, nausea, or other side effects Signs of nutritional deficiency , including unusual fatigue, weakness, hair loss, brittle nails, frequent infections, or poor wound healing Pre-existing eating disorders or disordered eating patterns, as GLP-1 medications may complicate these conditions Complex medical conditions such as chronic kidney disease, liver disease, or malabsorption disorders requiring specialised dietary management Pregnancy or breastfeeding GLP-1 medications should not be used during pregnancy

Working with a nutrition pro can help

Given the immunosuppressive features of cannabis smoke on lung macrophages, a similar response could occur, although more research is needed to understand the impact of cannabis smoke and cannabinoids on macrophage efferocytosis and whether such changes are beneficial or detrimental